Pinned Tweet
We recently reported diabetes care target attainment in 316,947 adults receiving care in Mexico’s federalized public health system.
Against WHO Global Diabetes Compact 2030 minimum targets:
🎯 HbA1c <8%: 59.3%
🎯 BP <140/90 mmHg: 76.6%
🎯 Statin use ≥40 y: 30.2%
👇
We recently reported how routine clinical data can support hypertension care monitoring at scale in Mexico.
Among 322,661 adults in active follow-up:
• 67.2% had BP <140/90 mmHg
• 36.8% had BP <130/80 mmHg
👇
📄 doi.org/10.1177/117863292614…
1
1
62
Among patients with suboptimal BP control:
• 63.8% had follow-up within 4 weeks
• 48.1% had treatment intensification
Continuous monitoring can identify care gaps and guide targeted improvement.
Evidence into better health decisions.
#Hypertension #PrimaryCare #HealthSystems
27
Continuous performance monitoring can identify where improvement is most needed and help guide targeted action in primary care.
📄 doi.org/10.3389/fcdhc.2026.1…
Evidence into better health decisions.
#Diabetes #PrimaryCare #HealthSystems
1
42
More than 1 in 2 adults with type 2 diabetes had MASLD in our primary care cohort in Mexico.
And 22.7% had intermediate-to-high fibrosis risk.
Liver disease is already a major part of diabetes care.
🤖 Made with AI
A key finding: 57% of adults with MASLD and 43.6% of those with increased fibrosis risk had normal liver enzymes.
ALT/AST alone may miss many patients.
📄 doi.org/10.1016/j.clinme.202…
Evidence into better health decisions.
#MASLD #Diabetes #PrimaryCare
52
Recently, we examined diabetes-related complications in adults with type 2 diabetes receiving primary care in Mexico.
70.5% already had at least one diabetes-related complication.
Are we identifying complications early enough?
👇
Complications were associated with a progressive decline in health-related quality of life, reinforcing the importance of prevention, systematic screening, and timely intervention in primary care.
📄 doi.org/10.3389/fcdhc.2026.1…
Evidence into better health decisions.
#Diabetes
Contento de compartir nuestra nueva publicación👇
"Cumulative burden of diabetes-related complications and health-related quality of life in primary care: a cross sectional study from Mexico"
frontiersin.org/journals/cli…
Exploramos la presencia de complicaciones por diabetes y su asociación con los diferentes aspectos relacionados a la calidad de vida en personas atendidas en el primer nivel de atención en #México 🇲🇽.
1
158
En la atención de enfermedades crónicas el objetivo principal, después de todo, es preservar y optimizar la #calidaddevida.
Planteamos la relevancia de un enfoque centrado en la calidad de vida y el fortalecimiento del primer nivel de atención para mitigar la carga por #diabetes
114
We are pleased to share the preliminary results of a care strategy for diabetes prevention among individuals with prediabetes, implemented within Mexico's public health system. 🇲🇽
👇
doi.org/10.1016/j.clinme.202…
#diabetes #prediabetes #Mexico
Con satisfacción comparto los resultados preliminares de una estrategia de atención para la prevención de diabetes en personas con prediabetes, implementada en el sistema de salud pública de México🇲🇽
👇
doi.org/10.1016/j.clinme.202…
#diabetes #prediabetes #Mexico
Proud to share our recent findings on sarcopenia and morphofunctional changes in people with type 2 diabetes in Mexico at IDF Congress 2025; and returning with plenty of new ideas to improve diabetes care in our country #IDF2025 @IntDiabetesFed
Tuve la oportunidad de participar en la elaboración del Protocolo Nacional de Atención Médica para Diabetes tipo 2.
👇
pronamsalud.csg.gob.mx
pronamsalud.csg.gob.mx/infog…
En la medida que logremos incorporar estas intervenciones basadas en evidencia en la atención de nuestros pacientes, estaremos incidiendo en la calidad de vida y pronóstico de una de las condiciones de mayor impacto en nuestra población.
1
1
410
Además incluimos el Manual para Personas que Viven con Diabetes desarrollado en la Clínica de Diabetes Ciudad de México de nuestro IMSS-Bienestar. Les invito a conocer estos documentos.
pronamsalud.csg.gob.mx/manua…
I’ll be presenting at the IDF Congress on April 9 in Bangkok! #IDF2025 @IntDiabetesFed #diabetes #sarcopenia #primarycare #Mexico
6
364
Investigamos la prevalencia de alteraciones morfofuncionales, incluyendo sarcopenia, en personas con diabetes en el primer nivel de atención. 👇🏼
sciencedirect.com/science/ar…
We investigated the prevalence of altered morphofunctional phenotypes, including sarcopenia, in primary care settings.
@caml1225
Prevalence of diabetes-related sarcopenia... sciencedirect.com/science/ar…
@kamleshkhunti @felipeisidro13 @DrMijailTapia @DiegoBellido2
4
526

















